PharmGen Science, Inc. (004720.KS) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 5Aug 10Aug 13Aug 19Aug 24Aug 27Sep 1Sep 4

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

5.8x

Market Cap

KRW 68.94B

MomentumView details →

1D Return

−0.63%

YTD Return

−26.11%

RSI (14)

39.4

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

5.8x

Market Cap

KRW 68.94B

RSI (14)

39.4

MomentumView details →

1D Return

−0.63%

YTD Return

−26.11%

ProfitabilityView details →

Gross Margin

64.26%

Net Margin

−76.62%

EBITDA Margin

4.90%

ROE (TTM)

−95.95%

ROA (TTM)

−72.95%

Asset Turnover

0.92x

GrowthView details →

Revenue YoY

+0.42%

EPS YoY

—

FCF YoY

+496.43%

Revenue CAGR 3Y

+4.67%

EPS CAGR 3Y

—

EBITDA YoY

−3.42%

EarningsView details →

EPS (Actual)

—

EPS Surprise

—

Beats (12Q)

—

Next Q EPS Est

—

Avg Surprise (4Q)

—

Rev Surprise

—

Capital & dividendView details →

Debt/Equity

0.00x

Current Ratio

3.33x

Quick Ratio

2.41x

Div Yield

—

Div Rate

—

Div Growth 1Y

—

Financials snapshotView financials →

Revenue (TTM)

175.36B

Net Income (TTM)

−134.36B

Op. CF (TTM)

17.33B

Latest newsMore news →

No recent news for 004720.KS.

Similar companies

片仔癀600436.SH GSK plcGSK SanofiSNY CSPC Pharmaceutical Group Limited01093.HK Bristol-Myers Squibb CompanyBMY Biogen Inc.BIIB Find similar companies →

Latest newsMore news →

No recent news for 004720.KS.